Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study

Monique K van der Kooij, Arjen Joosse, Karijn P M Suijkerbuijk, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Marye J Boers-Sonderen, Alfonsus J M van den Eertwegh, Jan Willem B de Groot, John B A G Haanen, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, Astrid A M van der Veldt, Gerard Vreugdenhil, Hans M Westgeest, Michel W J M Wouters, Olaf M Dekkers, Ellen Kapiteijn

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)707-710
Number of pages4
JournalBritish journal of cancer
Volume128
Issue number5
DOIs
Publication statusPublished - Mar 2023

Keywords

  • Humans
  • Programmed Cell Death 1 Receptor/therapeutic use
  • Cohort Studies
  • Melanoma/drug therapy
  • Nivolumab/therapeutic use

Cite this